

Prof Angela Tincani
Professor Angela Tincani is a senior consultant (previously director) at the Rheumatology and Clinical Immunology Unit of Aziende Socio Sanitaria Territoriali (ASST)-Spedali Civili and University of Brescia, Italy.
Professor Tincani has been involved in several international committees for education and research in the field of systemic autoimmune diseases. Professor Tincani’s primary clinical and research interests include the use of anti-rheumatic drugs in pregnant and lactating patients and the management of pregnancy in rheumatic disease patients, in addition to evaluating autoantibodies and autoimmune diseases as risk factors for poor gestational outcomes. She served as an expert for several European Alliance of Associations for Rheumatology (EULAR) recommendations, including “Points to consider for use of anti-rheumatic drugs before pregnancy and during pregnancy and lactation”. Together with Professor Andreoli, Professor Tincani is co-principal investigator of the “Italian Registry of Pregnancy in Rheumatic Diseases”.
Here, patients can find everything they need to know about HS, from common triggers and management options to the types of specialists involved in HS care
Intended for general practitioners who are referring patients with HS to dermatologists when mild-to-moderate HS has not responded to first-line treatment
This template is intended for general practitioners looking to refer patients with suspected or severe HS to dermatologists in secondary care
This infographic outlines the six proposed stages of HS pathogenesis and highlights the immune cells involved in the progression of HS
The symptoms of HS go beyond skin deep. For the true burden of HS and to facilitate holistic care, see the full list of symptoms that patients may experience
Can you spot the signs and symptoms of HS? Take a look at our algorithm that aims to aid a diagnosis of HS